Clinical application of mouth-retrofitted stent in prevention of esophageal restenosis after esophageal stent implantation

Guang-yu ZHU,Gao-jun TENG,Jin-he GUO,Shi-cheng HE,Gang DENG,Wen FANG,Guo-zhao LI

DOI: https://doi.org/10.3969/j.issn.1008-794X.2011.06.007

2011-01-01

Abstract:Objective: To evaluate the mouth-retrofitted stent in preventing esophageal restenosis after esophageal stent implantation, and to discuss its safety in clinical use. Methods: Mouth-retrofitted stent implantation was carried out in 10 patients with pathologically and radiologically confirmed esophageal carcinoma. The mouth part of the stent used in the treatment was covered with silica gel membrane. After the treatment, the patients were followed up monthly to determine the severity of dysphagia, which was assessed by using Stooler's score, X-ray. Chest CT scanning and esophagography were performed to observe the location of the stent and to clarify if there was any obstruction. The gastroscopy was bimonthly performed in all patients to see whether or not stent restenosis occurred. If stent restenosis occurred, biopsy examination was used in order to determine its etiology. During the follow-up period, the related complications such as serious chest pain, hemorrhage, pneumonia, trancheoesophageal fistula, etc. were closely observed. Results: All the 10 patients were followed up for 4-10 months. The Stooler's score for dysphagia was 0 to 1 grade in 9 cases. The severity of dysphagia was gradually increased in one case and its grade reached 3 at 5 months after the procedure. After operation, no stent migration occurred in 9 cases; in 1 case who had received treatment with the stent loaded with 125I seeds the stent migrated into the stomach after 8 months although both esophagography and gastroscopy showed that the esophageal inner wall of the former stenotic lumen was smooth with no stenosis. In the patient who had gradual increased dysphagia, chest CT scanning showed that the lesion exceeded the superior edge of the stent, and both esophagography and gastroscopy confirmed that the restenosis was caused by tumor proliferation. In the remaining 8 patients, the length of lesions was not obviously increased, and the mouth part of the stent showed no stenosis. Esophagographic and gastroscopic examinations showed that no esophageal obstruction existed. After the therapy the thickness of lesions was increased in 4 patients who used the stent without 125I seeds and the thickness of lesions was decreased in other 4 patients who used the stent with 125I seeds. After operation, all patients experienced slight chest pain and throat discomfort, which were relieved after symptomatic medication. No serious complications occurred. Conclusion: Mouth-retrofitted stent is very effective in preventing the esophageal restenosis occurred after the esophageal stent implantation. Besides, this technique is quite safe.